EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma

Li Sun iD, Mu Xu, Guoying Zhang iD, Lin Dong, Jie Wu, Chenchen Wei, Kexin Xu, Lu Zhang

International Journal of Genomics · 27.12.2021 · 2021 · 1-10

DOI: 10.1155/2021/1326463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Genomics, erschienen am 27.12.2021. Verfasst von Li Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine Center, the Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 789 Outstanding Talent Program of SAHNMU, Postdoctoral Research Fund of Jiangsu Province, China Postdoctoral Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide with high mortality, and there is an urgent need of new diagnosis measures. This study is aimed at investigating whether circulating exosomal miRNAs could act as biomarkers for the diagnosis of HCC.

Methods

A four-stage strategy was adopted in this study. Candidate miRNA was selected by comprehensive analysis of four GEO datasets and TCGA database. The expression of candidate miRNAs in serum exosomal samples were examined through qRT-PCR. The diagnostic utility of the final validated miRNAs was examined by receiver operating characteristic (ROC) curve analysis.

Results

After synthetical analysis of four GEO datasets, six miRNAs were selected as candidates due to their higher differential fold change. miR-101 and miR-125b were selected as candidate miRNAs to further investigate their potential as biomarkers for HCC due to their differential fold change and their influence on overall survival based on the TCGA database. As a result, miR-101 and miR-125b expressions were remarkably downregulated in both tissues and serum exosomes of patients with HCC. The area under the ROC curves (AUCs) of circulating exosomal miR-101 and miR-125b were 0.894 (95% CI, 0.793–0.994) and 0.812 (95% CI, 0.675–0.950), respectively. The combination of the two miRNAs presented higher diagnostic utility for HCC ( AUC = 0.953 ).

Conclusion

The exosomal miR-101 and miR-125b panel in the serum may act as a noninvasive biomarker for HCC detection.

Autor:innen und Institutionen

  • Laboratory Medicine Center, the Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Clinical Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Clinical Laboratory, Nanjing Integrated Traditional Chinese and Western Medicine Hospital, Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu, China.
  • Cancer Medical Center, the Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.

ORCID-Profile: Li Sun, Guoying Zhang

Förderung

  • 789 Outstanding Talent Program of SAHNMU
  • Postdoctoral Research Fund of Jiangsu Province
  • China Postdoctoral Science Foundation
  • Health Commission of Jiangsu
  • Science and National Nature Science Foundation of China

Zitieren

APA

Sun, L., Xu, M., Zhang, G., Dong, L., Wu, J., Wei, C., Xu, K., & Zhang, L. (2021). Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma. International Journal of Genomics, 2021, 1-10. https://doi.org/10.1155/2021/1326463

Vancouver

Sun L, Xu M, Zhang G, Dong L, Wu J, Wei C, et al. Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma. International Journal of Genomics. 2021;2021:1-10. doi:10.1155/2021/1326463

BibTeX
@article{Sun2021,
  author = {Sun, Li and Xu, Mu and Zhang, Guoying and Dong, Lin and Wu, Jie and Wei, Chenchen and Xu, Kexin and Zhang, Lu},
  title = {Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma},
  journal = {International Journal of Genomics},
  year = {2021},
  volume = {2021},
  pages = {1--10},
  doi = {10.1155/2021/1326463}
}
Kostenlos starten →